false 0001593549 0001593549 2025-02-18 2025-02-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 18, 2025

 

 

 

Livento Group, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Nevada   000-56457   49-3999052
(State or Other Jurisdiction   (Commission   (I.R.S. Employer
of Incorporation)   File Number)   Identification No.)

 

17 Stete Street, Suite 4000 NY 10004

(Address of Principal Executive Office) (Zip Code)

 

980-432-8241

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value per share   NUGN   OTC Pink

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

On August 1, 2022 the company issued a convertible note in the principal amount of $70,000.00 to Durotar, Ltd. which Durotar funded the same day. The Company inadvertently failed to disclose the Note in its SEC filings. The company is disclosing the Note in good faith at this time to accommodate a bona fide purchaser of the Note in its efforts to convert the Note and liquidate conversion shares derived from Note conversions.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: February 18, 2025

 

  /s/ David Stybr
  David Stybr
  President Livento Group Inc.
  (formerly NuGene International, Inc.)

 

 

 

v3.25.0.1
Cover
Feb. 18, 2025
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Feb. 18, 2025
Entity File Number 000-56457
Entity Registrant Name Livento Group, Inc.
Entity Central Index Key 0001593549
Entity Tax Identification Number 49-3999052
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 17 Stete Street
Entity Address, City or Town Suite 4000
Entity Address, State or Province NY
Entity Address, Postal Zip Code 10004
City Area Code 980
Local Phone Number 432-8241
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.0001 par value per share
Trading Symbol NUGN
Entity Emerging Growth Company false
NuGene (PK) (USOTC:NUGN)
Historical Stock Chart
From Mar 2025 to Apr 2025 Click Here for more NuGene (PK) Charts.
NuGene (PK) (USOTC:NUGN)
Historical Stock Chart
From Apr 2024 to Apr 2025 Click Here for more NuGene (PK) Charts.